scPharmaceuticals | 8-K: Current report
scPharmaceuticals | 10-Q: Quarterly report
scPharmaceuticals | 8-K: Current report
scPharmaceuticals | SC 13G: Statement of acquisition of beneficial ownership by individuals-Laurence W. Lytton(5.1%)
scPharmaceuticals | DEFA14A: Others
scPharmaceuticals | DEF 14A: Definitive information statements
scPharmaceuticals | PRE 14A: Preliminary proxy statements relating to merger or acquisition
scPharmaceuticals | SC 13G/A: Statement of acquisition of beneficial ownership by individuals (Amendment)-BlackRock, Inc.(4.99%)
scPharmaceuticals | 4: Statement of changes in beneficial ownership of securities-Officer Tucker John H
scPharmaceuticals | EFFECT: Others
scPharmaceuticals | 424B5: Prospectus
scPharmaceuticals | CORRESP: CORRESP
scPharmaceuticals | UPLOAD: Others
scPharmaceuticals | S-8: Initial registration statement for securities to be offered to employees pursuant to employee benefit plans
scPharmaceuticals | S-3: Registration statement for specified transactions by certain issuers
scPharmaceuticals | 10-K: Annual report
scPharmaceuticals | 8-K: Current report
scPharmaceuticals | SC 13G/A: Statement of acquisition of beneficial ownership by individuals (Amendment)-Andrew J. Schwab(3.3%),5AM Partners IV, LLC(2.8%), etc.
scPharmaceuticals | SC 13G/A: Statement of acquisition of beneficial ownership by individuals (Amendment)-Armistice Capital, LLC(0%),Steven Boyd(0%)
scPharmaceuticals | SC 13G: Statement of acquisition of beneficial ownership by individuals-Rubric Capital Management LP(9.76%),David Rosen(9.76%)
No Data